Literature DB >> 25984451

A new polymer-free drug-eluting stent with nanocarriers eluting sirolimus from stent-plus-balloon compared with bare-metal stent and with biolimus A9 eluting stent in porcine coronary arteries.

Celso K Takimura1, Micheli Z Galon1, Paulo S Gutierrez1, Prakash Sojitra1, Ashwin Vyas1, Manish Doshi1, Pedro A Lemos1.   

Abstract

BACKGROUND: Permanent polymers in first generation drug-eluting stent (DES) have been imputed to be a possible cause of persistent inflammation, remodeling, malapposition and late stent thrombosis. We aim to describe the in vivo experimental result of a new polymer-free DES eluting sirolimus from stent-plus-balloon (Focus np stent, Envision Scientific) compared with a bare-metal stent (BMS) (Amazonia CroCo, Minvasys) and with a biolimus A9 eluting stent (Biomatrix, Biosensors).
METHODS: In 10 juvenile pigs, 23 coronary stents were implanted in the coronary arteries (8 Amazonia CroCo, 8 Focus np, and 7 Biomatrix). At 28-day follow-up, optical coherence tomography (OCT) and histology were used to evaluate neointimal hyperplasia and healing response.
RESULTS: According to OCT analysis, Focus np stents had a greater lumen area and less neointimal hyperplasia response than BMS and Biomatrix had. Histomorphometry results showed less neointimal hyperplasia in Focus np than in BMS. Histology showed a higher fibrin deposition in Biomatrix stent compared to Focus np and BMS.
CONCLUSIONS: The new polymer-free DES with sirolimus eluted from stent-plus-balloon demonstrated safety and reduced neointimal proliferation compared with the BMS and Biomatrix stents at 28-day follow-up in this porcine coronary model. This new polymer-free DES is promising and warrants further clinical studies.

Entities:  

Keywords:  Neointimal; restenosis; stent; vascular injury

Year:  2015        PMID: 25984451      PMCID: PMC4420674          DOI: 10.3978/j.issn.2223-3652.2015.03.08

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  24 in total

Review 1.  The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents.

Authors:  Harry C Lowe; Robert S Schwartz; Briain D Mac Neill; Ik-Kyung Jang; Motoya Hayase; Campbell Rogers; Stephen N Oesterle
Journal:  Catheter Cardiovasc Interv       Date:  2003-12       Impact factor: 2.692

2.  A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions.

Authors:  Didier Carrié; Jacques Berland; Stefan Verheye; Karl Eugen Hauptmann; Mathias Vrolix; Roberto Violini; Alain Dibie; Sergio Berti; Eric Maupas; David Antoniucci; Joachim Schofer
Journal:  J Am Coll Cardiol       Date:  2012-01-25       Impact factor: 24.094

3.  Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter.

Authors:  Pedro A Lemos; Vasim Farooq; Celso K Takimura; Paulo S Gutierrez; Renu Virmani; Frank Kolodgie; Uwe Christians; Alexander Kharlamov; Manish Doshi; Prakash Sojitra; Heleen M M van Beusekom; Patrick W Serruys
Journal:  EuroIntervention       Date:  2013-05-20       Impact factor: 6.534

4.  In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries.

Authors:  Ron Waksman; Rajbabu Pakala; Richard Baffour; Rufus Seabron; David Hellinga; Rosanna Chan; Shih-Horng Su; Frank Kolodgie; Renu Virmani
Journal:  Catheter Cardiovasc Interv       Date:  2011-12-01       Impact factor: 2.692

5.  Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.

Authors:  Norio Tada; Renu Virmani; Gordon Grant; Lauren Bartlett; Alexander Black; Claudia Clavijo; Uwe Christians; Ron Betts; Doug Savage; Shih-Horng Su; John Shulze; Saibal Kar
Journal:  Circ Cardiovasc Interv       Date:  2010-04       Impact factor: 6.546

6.  In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.

Authors:  R Kornowski; M K Hong; F O Tio; O Bramwell; H Wu; M B Leon
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

7.  Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.

Authors:  Alexandra J Lansky; Ricardo A Costa; Gary S Mintz; Yoshihiro Tsuchiya; Mark Midei; David A Cox; Charles O'Shaughnessy; Robert A Applegate; Louis A Cannon; Michael Mooney; Anthony Farah; Mark A Tannenbaum; Steven Yakubov; Dean J Kereiakes; S Chiu Wong; Barry Kaplan; Ecaterina Cristea; Gregg W Stone; Martin B Leon; William D Knopf; William W O'Neill
Journal:  Circulation       Date:  2004-04-12       Impact factor: 29.690

8.  Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.

Authors:  Stéphane Cook; Elena Ladich; Gaku Nakazawa; Parham Eshtehardi; Michel Neidhart; Rolf Vogel; Mario Togni; Peter Wenaweser; Michael Billinger; Christian Seiler; Steffen Gay; Bernhard Meier; Werner J Pichler; Peter Jüni; Renu Virmani; Stephan Windecker
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

Review 9.  Intracoronary optical coherence tomography: a comprehensive review clinical and research applications.

Authors:  Hiram G Bezerra; Marco A Costa; Giulio Guagliumi; Andrew M Rollins; Daniel I Simon
Journal:  JACC Cardiovasc Interv       Date:  2009-11       Impact factor: 11.195

10.  Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries.

Authors:  Nieves Gonzalo; Patrick W Serruys; Héctor M García-García; Gijs van Soest; Takayuki Okamura; Jurgen Ligthart; Michiel Knaapen; Stefan Verheye; Nico Bruining; Evelyn Regar
Journal:  Rev Esp Cardiol       Date:  2009-06       Impact factor: 4.753

View more
  2 in total

Review 1.  Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy.

Authors:  Aleena Mary Cherian; Shantikumar V Nair; Vijayakumar Maniyal; Deepthy Menon
Journal:  APL Bioeng       Date:  2021-06-01

2.  A GLP-1 Analog Liraglutide Reduces Intimal Hyperplasia After Coronary Stent Implantation via Regulation of Glycemic Variability and NLRP3 Inflammasome/IL-10 Signaling in Diabetic Swine.

Authors:  Jinggang Xia; Qinxue Li; Yayun Liu; Quanxin Ren; Jinhuan Gao; Yi Tian; Jubo Li; Baojie Zhang; Haichen Sun; Shuang Liu
Journal:  Front Pharmacol       Date:  2020-03-26       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.